The emergence of preventative medicines will have a profound impact on the ability to improve patient outcomes and reduce healthcare costs associated with chronic diseases, according to PhRMA’s latest Medicines in Development report.
Nearly 1,200 medicines are in R&D pipeline to combat expensive chronic diseases
